Cell-free DNA: Comparison of Technologies

Clinics in Laboratory Medicine

Volumn 36, Issue 2, 2016, Pages 199-211

  Dar, Pe'er ^a   Shani, Hagit ^a   Evans, Mark I ^b,c  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c Comprehensive Genetics and Fetal Medicine Foundation of America ^*  (United States)

Author keywords

Cell free fetal DNA; DNA methylation; Multiple parallel shotgun sequencing; Next generation sequencing; Noninvasive prenatal screening; Selected probes; Selective sequencing; Single nucleotide polymorphisms

Indexed keywords

CELL FREE DNA; DNA; DNA FRAGMENT; FETAL RNA; RNA; UNCLASSIFIED DRUG;

ANEUPLOIDY; COMPARATIVE STUDY; DNA DETERMINATION; DNA ISOLATION; DNA SEQUENCE; ENDOCERVICAL FETAL TROPHOBLAST; FETAL FRACTION; FETUS CELL; GENE; GENETIC SCREENING; HUMAN; MASSIVE PARALLEL SHOTGUN SEQUENCING; MATERNAL PLASMA; MATERNAL SERUM SCREENING TEST; METHYLATED DNA BASED ASSAY; PARAMETERS CONCERNING THE FETUS, NEWBORN AND PREGNANCY; PLAC4 GENE; PREDICTIVE VALUE; PRENATAL SCREENING; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TARGETED MASSIVE PARALLEL SHOTGUN SEQUENCING; TROPHOBLAST; BLOOD; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; FEMALE; HIGH THROUGHPUT SEQUENCING; PRENATAL DIAGNOSIS; PROCEDURES;

ANEUPLOIDY; DNA; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC TESTING; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PRENATAL DIAGNOSIS; SEQUENCE ANALYSIS, DNA;

EID: 84961233537     PISSN: 02722712     EISSN: 15579832     Source Type: Journal    
DOI: 10.1016/j.cll.2016.01.015     Document Type: Review

References (81)

1. Evans M.I., Wapner R.J. Invasive prenatal diagnostic procedures 2005. Semin Perinatol 2005, 29(4):215-218.
2. Evans M.I., Johnson M.P., Yaron Y., et al. Prenatal diagnosis: genetics, reproductive risks, testing and management 2006, McGraw-Hill, New York.
3. Evans M.I., Krivchenia E.L., Wapner R.J., et al. Principles of screening. Clin Obstet Gynecol 2002, 45(3):657-660. [discussion: 730-2].
4. Bianchi D.W., Simpson J.L., Jackson L.G., et al. Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data. National Institute of Child Health and Development Fetal Cell Isolation Study. Prenat Diagn 2002, 22(7):609-615.
5. Herzenberg L.A., Bianchi D.W., Schroder J., et al. Fetal cells in the blood of pregnant women: detection and enrichment by fluorescence-activated cell sorting. Proc Natl Acad Sci U S A 1979, 76(3):1453-1455.
6. Hahn S., Holzgreve W. Fetal cells and fetal DNA in maternal blood: new developments for a new millennium 2001, Karger, Basel (Switzerland).
7. Holzgreve W., Zhong X.Y., Troeger C., et al. Fetal cells and fetal DNA in maternal blood: an overview of the Basel experience. Fetal cells and fetal DNA in maternal blood: new developments for a new millennium 2001, Karger, Basel (Switzerland). W. Holzgreve, S. Hahn (Eds.).
8. Lo Y.M., Corbetta N., Chamberlain P.F., et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997, 350(9076):485-487.
9. Lo Y.M., Tein M.S., Lau T.K., et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998, 62(4):768-775.
10. Heung M.M., Tsui N.B., Leung T.Y., et al. Development of extraction protocols to improve the yield for fetal RNA in maternal plasma. Prenat Diagn 2009, 29(3):277-279.
11. Norton M.E., Brar H., Weiss J., et al. Non-invasive Chromosomal Evaluation (NICE) study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012, 207(2):137.e1-137.e8.
12. Palomaki G.E., Deciu C., Kloza E.M., et al. DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Genet Med 2012, 14(3):296-305.
13. Palomaki G.E., Kloza E.M., Lambert-Messerlian G.M., et al. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med 2011, 13(11):913-920.
14. Verweij E.J., Jacobsson B., van Scheltema P.A., et al. European Non-invasive Trisomy Evaluation (EU-NITE) study: a multicenter prospective cohort study for non-invasive fetal trisomy 21 testing. Prenat Diagn 2013, 33(10):996-1001.
15. Samango-Sprouse C., Banjevic M., Ryan A., et al. SNP-based non-invasive prenatal testing detects sex chromosome aneuploidies with high accuracy. Prenat Diagn 2013, 33(7):643-649.
16. Nicolaides K.H., Syngelaki A., Gil M., et al. Validation of targeted sequencing of single-nucleotide polymorphisms for non-invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y. Prenat Diagn 2013, 33(6):575-579.
17. Mazloom A.R., Dzakula Z., Oeth P., et al. Noninvasive prenatal detection of sex chromosomal aneuploidies by sequencing circulating cell-free DNA from maternal plasma. Prenat Diagn 2013, 33(6):591-597.
18. Sehnert A.J., Rhees B., Comstock D., et al. Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood. Clin Chem 2011, 57(7):1042-1049.
19. Sparks A.B., Struble C.A., Wang E.T., et al. Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012, 206(4):319.e1-319.e9.
20. Sparks A.B., Wang E.T., Struble C.A., et al. Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy. Prenat Diagn 2012, 32(1):3-9.
21. Ehrich M., Deciu C., Zwiefelhofer T., et al. Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. Am J Obstet Gynecol 2011, 204(3):205.e1-205.e11.
22. Zimmermann B., Hill M., Gemelos G., et al. Noninvasive prenatal aneuploidy testing of chromosomes 13, 18, 21, X, and Y, using targeted sequencing of polymorphic loci. Prenat Diagn 2012, 32(13):1233-1241.
23. Fan H.C., Blumenfeld Y.J., Chitkara U., et al. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci U S A 2008, 105(42):16266-16271.
24. Bianchi D.W., Platt L.D., Goldberg J.D., MatErnal BLood IS Source to Accurately diagnose fetal aneuploidy (MELISSA) Study Group, et al. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol 2012, 119(5):890-901.
25. Ashoor G., Syngelaki A., Wagner M., et al. Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012, 206(4):322.e1-322.e5.
26. Ashoor G., Syngelaki A., Wang E., et al. Trisomy 13 detection in the first trimester of pregnancy using a chromosome-selective cell-free DNA analysis method. Ultrasound Obstet Gynecol 2013, 41(1):21-25.
27. Nicolaides K.H., Wright D., Poon L.C., et al. First-trimester contingent screening for trisomy 21 by biomarkers and maternal blood cell-free DNA testing. Ultrasound Obstet Gynecol 2013, 42(1):41-50.
28. Zhang H., Gao Y., Jiang F., et al. Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies. Ultrasound Obstet Gynecol 2015, 45(5):530-538.
29. Dar P., Curnow K.J., Gross S.J., et al. Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing. Am J Obstet Gynecol 2014, 211(5):527.e1-527.e17.
30. Ashoor G., Syngelaki A., Poon L.C., et al. Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks' gestation: relation to maternal and fetal characteristics. Ultrasound Obstet Gynecol 2013, 41(1):26-32.
31. Palomaki G.E., Kloza E.M., Lambert-Messerlian G.M., et al. Circulating cell free DNA testing: are some test failures informative?. Prenat Diagn 2015, 35(3):289-293.
32. Chan K.C., Zhang J., Hui A.B., et al. Size distributions of maternal and fetal DNA in maternal plasma. Clin Chem 2004, 50(1):88-92.
33. Li Y., Di Naro E., Vitucci A., et al. Detection of paternally inherited fetal point mutations for beta-thalassemia using size-fractionated cell-free DNA in maternal plasma. JAMA 2005, 293(7):843-849.
34. Choi H., Lau T.K., Jiang F.M., et al. Fetal aneuploidy screening by maternal plasma DNA sequencing: 'false positive' due to confined placental mosaicism. Prenat Diagn 2013, 33(2):198-200.
35. Harrison K.J., Barrett I.J., Lomax B.L., et al. Detection of confined placental mosaicism in trisomy 18 conceptions using interphase cytogenetic analysis. Hum Genet 1993, 92(4):353-358.
36. Li Y., Zimmermann B., Rusterholz C., et al. Size separation of circulatory DNA in maternal plasma permits ready detection of fetal DNA polymorphisms. Clin Chem 2004, 50(6):1002-1011.
37. Lun F.M., Tsui N.B., Chan K.C., et al. Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasma. Proc Natl Acad Sci U S A 2008, 105(50):19920-19925.
38. Dhallan R., Au W.C., Mattagajasingh S., et al. Methods to increase the percentage of free fetal DNA recovered from the maternal circulation. JAMA 2004, 291(9):1114-1119.
39. Papageorgiou E.A., Fiegler H., Rakyan V., et al. Sites of differential DNA methylation between placenta and peripheral blood: molecular markers for noninvasive prenatal diagnosis of aneuploidies. Am J Pathol 2009, 174(5):1609-1618.
40. Chim S.S., Jin S., Lee T.Y., et al. Systematic search for placental DNA-methylation markers on chromosome 21: toward a maternal plasma-based epigenetic test for fetal trisomy 21. Clin Chem 2008, 54(3):500-511.
41. Futch T., Spinosa J., Bhatt S., et al. Initial clinical laboratory experience in noninvasive prenatal testing for fetal aneuploidy from maternal plasma DNA samples. Prenat Diagn 2013, 33(6):569-574.
42. Chiu R.W., Chan K.C., Gao Y., et al. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci U S A 2008, 105(51):20458-20463.
43. Benn P., Cuckle H., Pergament E. Non-invasive prenatal testing for aneuploidy: current status and future prospects. Ultrasound Obstet Gynecol 2013, 42(1):15-33.
44. Chen E.Z., Chiu R.W., Sun H., et al. Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing. PLoS One 2011, 6(7):e21791.
45. Yeang C.H., Ma G.C., Hsu H.W., et al. Genome-wide normalized score: a novel algorithm to detect fetal trisomy 21 during non-invasive prenatal testing. Ultrasound Obstet Gynecol 2014, 44(1):25-30.
46. Dan S., Wang W., Ren J., et al. Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11,105 pregnancies with mixed risk factors. Prenat Diagn 2012, 32(13):1225-1232.
47. Song Y., Liu C., Qi H., et al. Noninvasive prenatal testing of fetal aneuploidies by massively parallel sequencing in a prospective Chinese population. Prenat Diagn 2013, 33(7):700-706.
48. Lau T.K., Chen F., Pan X., et al. Noninvasive prenatal diagnosis of common fetal chromosomal aneuploidies by maternal plasma DNA sequencing. J Matern Fetal Neonatal Med 2012, 25(8):1370-1374.
49. Stokowski R., Wang E., White K., et al. Clinical performance of non-invasive prenatal testing (NIPT) using targeted cell-free DNA analysis in maternal plasma with microarrays or next generation sequencing (NGS) is consistent across multiple controlled clinical studies. Prenat Diagn 2015, 35(12):1243-1246.
50. Liao G.J., Chan K.C., Jiang P., et al. Noninvasive prenatal diagnosis of fetal trisomy 21 by allelic ratio analysis using targeted massively parallel sequencing of maternal plasma DNA. PLoS One 2012, 7(5):e38154.
51. Dhallan R., Guo X., Emche S., et al. A non-invasive test for prenatal diagnosis based on fetal DNA present in maternal blood: a preliminary study. Lancet 2007, 369(9560):474-481.
52. Fan H.C., Gu W., Wang J., et al. Non-invasive prenatal measurement of the fetal genome. Nature 2012, 487(7407):320-324.
53. Tong Y.K., Ding C., Chiu R.W., et al. Noninvasive prenatal detection of fetal trisomy 18 by epigenetic allelic ratio analysis in maternal plasma: theoretical and empirical considerations. Clin Chem 2006, 52(12):2194-2202.
54. Old R.W., Crea F., Puszyk W., et al. Candidate epigenetic biomarkers for non-invasive prenatal diagnosis of Down syndrome. Reprod Biomed Online 2007, 15(2):227-235.
55. Tong Y.K., Jin S., Chiu R.W., et al. Noninvasive prenatal detection of trisomy 21 by an epigenetic-genetic chromosome-dosage approach. Clin Chem 2010, 56(1):90-98.
56. Papageorgiou E.A., Karagrigoriou A., Tsaliki E., et al. Fetal-specific DNA methylation ratio permits noninvasive prenatal diagnosis of trisomy 21. Nat Med 2011, 17(4):510-513.
57. Lun F.M., Chiu R.W., Sun K., et al. Noninvasive prenatal methylomic analysis by genomewide bisulfite sequencing of maternal plasma DNA. Clin Chem 2013, 59(11):1583-1594.
58. Poon L.L., Leung T.N., Lau T.K., et al. Presence of fetal RNA in maternal plasma. Clin Chem 2000, 46(11):1832-1834.
59. Tsui N.B., Ng E.K., Lo Y.M. Stability of endogenous and added RNA in blood specimens, serum, and plasma. Clin Chem 2002, 48(10):1647-1653.
60. Tsui N.B., Jiang P., Wong Y.F., et al. Maternal plasma RNA sequencing for genome-wide transcriptomic profiling and identification of pregnancy-associated transcripts. Clin Chem 2014, 60(7):954-962.
61. Go A.T., Visser A., Mulders M.A., et al. Detection of placental transcription factor mRNA in maternal plasma. Clin Chem 2004, 50(8):1413-1414.
62. Lo Y.M., Tsui N.B., Chiu R.W., et al. Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection. Nat Med 2007, 13(2):218-223.
63. Tsui N.B., Akolekar R., Chiu R.W., et al. Synergy of total PLAC4 RNA concentration and measurement of the RNA single-nucleotide polymorphism allelic ratio for the noninvasive prenatal detection of trisomy 21. Clin Chem 2010, 56(1):73-81.
64. Yang L., Sun H.Y., Chen D.Z., et al. Explore the dynamic alternation of gene PLAC4 mRNA expression levels in maternal plasma in second trimester for nonivasive detection of trisomy 21. Obstet Gynecol Sci 2015, 58(4):261-267.
65. Bianchi D.W., Klinger K.W., Vadnais T.J., et al. Development of a model system to compare cell separation methods for the isolation of fetal cells from maternal blood. Prenat Diagn 1996, 16(4):289-298.
66. Evans M.I., Hyett J., Nicolaides K.H. Genetic screening and clinical testing. High risk obstetrics in the requisites in obstetrics and gynecology 2008, 33-60. Elsevier Science, Philadelphia. E. Funai, M.I. Evans, J. Lockwood (Eds.).
67. Bischoff F.Z., Hahn S., Johnson K.L., et al. Intact fetal cells in maternal plasma: are they really there?. Lancet 2003, 361(9352):139-140.
68. Kilpatrick M.W., Tafas T., Evans M.I., et al. Automated detection of rare fetal cells in maternal blood: eliminating the false-positive XY signals in XX pregnancies. Am J Obstet Gynecol 2004, 190(6):1571-1578. [discussion: 1578-81].
69. Seppo A., Frisova V., Ichetovkin I., et al. Detection of circulating fetal cells utilizing automated microscopy: potential for noninvasive prenatal diagnosis of chromosomal aneuploidies. Prenat Diagn 2008, 28(9):815-821.
70. Huang R., Barber T.A., Schmidt M.A., et al. A microfluidics approach for the isolation of nucleated red blood cells (NRBCs) from the peripheral blood of pregnant women. Prenat Diagn 2008, 28(10):892-899.
71. Burgemeister R. New aspects of laser microdissection in research and routine. J Histochem Cytochem 2005, 53(3):409-412.
72. Hatt L., Brinch M., Singh R., et al. A new marker set that identifies fetal cells in maternal circulation with high specificity. Prenat Diagn 2014, 34(11):1066-1072.
73. Adinolfi M., Sherlock J. First trimester prenatal diagnosis using transcervical cells: an evaluation. Hum Reprod Update 1997, 3(4):383-392.
74. Fejgin M.D., Diukman R., Cotton Y., et al. Fetal cells in the uterine cervix: a source for early non-invasive prenatal diagnosis. Prenat Diagn 2001, 21(8):619-621.
75. Bussani C., Cioni R., Scarselli B., et al. Strategies for the isolation and detection of fetal cells in transcervical samples. Prenat Diagn 2002, 22(12):1098-1101.
76. Cioni R., Bussani C., Scarselli B., et al. Comparison of two techniques for transcervical cell sampling performed in the same study population. Prenat Diagn 2005, 25(3):198-202.
77. Rodeck C., Tutschek B., Sherlock J., et al. Methods for the transcervical collection of fetal cells during the first trimester of pregnancy. Prenat Diagn 1995, 15(10):933-942.
78. Massari A., Novelli G., Colosimo A., et al. Non-invasive early prenatal molecular diagnosis using retrieved transcervical trophoblast cells. Hum Genet 1996, 97(2):150-155.
79. Katz-Jaffe M.G., Mantzaris D., Cram D.S. DNA identification of fetal cells isolated from cervical mucus: potential for early non-invasive prenatal diagnosis. BJOG 2005, 112(5):595-600.
80. Cuckle H., Benn P., Pergament E. Maternal cfDNA screening for Down syndrome-a cost sensitivity analysis. Prenat Diagn 2013, 33(7):636-642.
81. Evans M.I., Sonek J.D., Hallahan T.W., et al. Cell-free fetal DNA screening in the USA: a cost analysis of screening strategies. Ultrasound Obstet Gynecol 2015, 45(1):74-83.